BTK and B-cell chronic lymphocytic leukemia: A male patient in his mid-sixties with chronic lymphocytic leukaemia (CLL), Binet stage B, receiving the Bruton’s tyrosine kinase (BtK) inhibitor acalabrutinib, presented with fever and other non-specific systemic symptoms.